Cargando…

Possible impact of the COVID-19 pandemic on the recreational use of nitrous oxide in the Paris area, France

INTRODUCTION: Recreational use of nitrous oxide (N(2)O) is increasing in Western countries, including France. During the COVID-19 pandemic, some authors warned that recreational N(2)O use could increase further as the supply of illicit drugs was impacted by various containment measures. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Dufayet, L., Caré, W., Laborde-Casterot, H., Chouachi, L., Langrand, J., Vodovar, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371623/
https://www.ncbi.nlm.nih.gov/pubmed/35773094
http://dx.doi.org/10.1016/j.revmed.2022.06.004
_version_ 1784767196041314304
author Dufayet, L.
Caré, W.
Laborde-Casterot, H.
Chouachi, L.
Langrand, J.
Vodovar, D.
author_facet Dufayet, L.
Caré, W.
Laborde-Casterot, H.
Chouachi, L.
Langrand, J.
Vodovar, D.
author_sort Dufayet, L.
collection PubMed
description INTRODUCTION: Recreational use of nitrous oxide (N(2)O) is increasing in Western countries, including France. During the COVID-19 pandemic, some authors warned that recreational N(2)O use could increase further as the supply of illicit drugs was impacted by various containment measures. METHODS: We retrospectively analyzed N(2)O exposures reported to the Paris Poison Control Center (France) from 2010/01/01 to 2021/04/15. The Poison Severity Score was used to grade severity. RESULTS: During the study period, 93 cases of N(2)O recreational exposures were reported (male/female ratio: 1.1; median age: 20.9 years range: [14.8-49.0]). The first case was reported in 2012, 84/93 (90%) and 65/93 (70%) were reported since 2019 and March 17(th) 2020 (first lockdown in France) respectively. Most of the patients were symptomatic (88/93; 95%) and developed neurological symptoms (78/93; 84%). Among the fourteen patients who developed moderate to severe symptoms, eleven were reported after March 2020. CONCLUSION: Despite a marked increase in recreational N(2)O exposures during the COVID-19 pandemic, the exact impact of COVID-19 on this increase remains to be determined as it was observed from 2019.
format Online
Article
Text
id pubmed-9371623
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-93716232022-08-12 Possible impact of the COVID-19 pandemic on the recreational use of nitrous oxide in the Paris area, France Dufayet, L. Caré, W. Laborde-Casterot, H. Chouachi, L. Langrand, J. Vodovar, D. Rev Med Interne Original Article INTRODUCTION: Recreational use of nitrous oxide (N(2)O) is increasing in Western countries, including France. During the COVID-19 pandemic, some authors warned that recreational N(2)O use could increase further as the supply of illicit drugs was impacted by various containment measures. METHODS: We retrospectively analyzed N(2)O exposures reported to the Paris Poison Control Center (France) from 2010/01/01 to 2021/04/15. The Poison Severity Score was used to grade severity. RESULTS: During the study period, 93 cases of N(2)O recreational exposures were reported (male/female ratio: 1.1; median age: 20.9 years range: [14.8-49.0]). The first case was reported in 2012, 84/93 (90%) and 65/93 (70%) were reported since 2019 and March 17(th) 2020 (first lockdown in France) respectively. Most of the patients were symptomatic (88/93; 95%) and developed neurological symptoms (78/93; 84%). Among the fourteen patients who developed moderate to severe symptoms, eleven were reported after March 2020. CONCLUSION: Despite a marked increase in recreational N(2)O exposures during the COVID-19 pandemic, the exact impact of COVID-19 on this increase remains to be determined as it was observed from 2019. Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. 2022-07 2022-06-15 /pmc/articles/PMC9371623/ /pubmed/35773094 http://dx.doi.org/10.1016/j.revmed.2022.06.004 Text en © 2022 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Dufayet, L.
Caré, W.
Laborde-Casterot, H.
Chouachi, L.
Langrand, J.
Vodovar, D.
Possible impact of the COVID-19 pandemic on the recreational use of nitrous oxide in the Paris area, France
title Possible impact of the COVID-19 pandemic on the recreational use of nitrous oxide in the Paris area, France
title_full Possible impact of the COVID-19 pandemic on the recreational use of nitrous oxide in the Paris area, France
title_fullStr Possible impact of the COVID-19 pandemic on the recreational use of nitrous oxide in the Paris area, France
title_full_unstemmed Possible impact of the COVID-19 pandemic on the recreational use of nitrous oxide in the Paris area, France
title_short Possible impact of the COVID-19 pandemic on the recreational use of nitrous oxide in the Paris area, France
title_sort possible impact of the covid-19 pandemic on the recreational use of nitrous oxide in the paris area, france
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371623/
https://www.ncbi.nlm.nih.gov/pubmed/35773094
http://dx.doi.org/10.1016/j.revmed.2022.06.004
work_keys_str_mv AT dufayetl possibleimpactofthecovid19pandemicontherecreationaluseofnitrousoxideintheparisareafrance
AT carew possibleimpactofthecovid19pandemicontherecreationaluseofnitrousoxideintheparisareafrance
AT labordecasteroth possibleimpactofthecovid19pandemicontherecreationaluseofnitrousoxideintheparisareafrance
AT chouachil possibleimpactofthecovid19pandemicontherecreationaluseofnitrousoxideintheparisareafrance
AT langrandj possibleimpactofthecovid19pandemicontherecreationaluseofnitrousoxideintheparisareafrance
AT vodovard possibleimpactofthecovid19pandemicontherecreationaluseofnitrousoxideintheparisareafrance